phosphoserine has been researched along with cp 31398 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Deiry, WS; Rastinejad, F; Takimoto, R; Wang, W | 1 |
1 other study(ies) available for phosphoserine and cp 31398
Article | Year |
---|---|
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Topics: Adenocarcinoma; Animals; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA-Binding Proteins; Doxorubicin; Female; Fibroblasts; Gene Expression Regulation; Genes, p53; Humans; Lung Neoplasms; Lymphocytes; Mice; Mice, Knockout; Neoplasm Proteins; Nuclear Proteins; Oncogene Proteins, Viral; Ovarian Neoplasms; Phosphorylation; Phosphoserine; Protein Binding; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Pyrimidines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Repressor Proteins; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin | 2003 |